Lyell Immunopharma reports safety data for lymphoma CAR T-cell therapy
Go back to Lyell Immunopharma reports safety data for lymphoma CAR T-cell therapy| (NASDAQ: LYEL) | Delayed: 11.84 -0.36 (2.95%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $12.20 | 52 Week High | $ | |||
| Open | $12.41 | 52 Week Low | $ | |||
| Day High | $13.00 | P/E | N/A | |||
| Day Low | $11.72 | EPS | $ | |||
| Volume | 81,474 | |||||
